First Horizon Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9M | Buy |
472,974
+26,599
| +6% | +$1.31M | 0.57% | 57 |
|
|
2025
Q1 | $27.2M | Buy |
446,375
+39,917
| +10% | +$2.33M | 0.77% | 37 |
|
|
2024
Q4 | $23M | Buy |
406,458
+11,072
| +3% | +$619K | 0.64% | 45 |
|
|
2024
Q3 | $20.5M | Buy |
395,386
+291,613
| +281% | +$13.7M | 0.57% | 57 |
|
|
2024
Q2 | $4.31M | Buy |
103,773
+1,632
| +2% | +$73K | 0.13% | 152 |
|
|
2024
Q1 | $5.54M | Buy |
102,141
+8,733
| +9% | +$445K | 0.17% | 140 |
|
|
2023
Q4 | $4.79M | Buy |
93,408
+2,075
| +2% | +$109K | 0.16% | 147 |
|
|
2023
Q3 | $5.3M | Sell |
91,333
-6,408
| -7% | -$393K | 0.19% | 136 |
|
|
2023
Q2 | $6.25M | Sell |
97,741
-548
| -0.6% | -$36.7K | 0.22% | 131 |
|
|
2023
Q1 | $6.81M | Buy |
98,289
+8,325
| +9% | +$587K | 0.24% | 115 |
|
|
2022
Q4 | $6.47M | Sell |
89,964
-3,531
| -4% | -$266K | 0.24% | 125 |
|
|
2022
Q3 | $6.65M | Sell |
93,495
-2,326
| -2% | -$169K | 0.27% | 114 |
|
|
2022
Q2 | $7.38M | Buy |
95,821
+11,255
| +13% | +$857K | 0.26% | 112 |
|
|
2022
Q1 | $6.18M | Sell |
84,566
-817
| -1% | -$54.9K | 0.34% | 88 |
|
|
2021
Q4 | $5.32M | Sell |
85,383
-94
| -0.1% | -$5.51K | 0.16% | 160 |
|
|
2021
Q3 | $5.06M | Buy |
85,477
+66,090
| +341% | +$4.35M | 0.17% | 166 |
|
|
2021
Q2 | $1.29M | Sell |
19,387
-1,576
| -8% | -$103K | 0.07% | 180 |
|
|
2021
Q1 | $1.32M | Buy |
20,963
+1,049
| +5% | +$65.3K | 0.08% | 171 |
|
|
2020
Q4 | $1.23M | Buy |
19,914
+273
| +1% | +$16.8K | 0.08% | 157 |
|
|
2020
Q3 | $1.18M | Sell |
19,641
-1,095
| -5% | -$65.9K | 0.09% | 156 |
|
|
2020
Q2 | $1.22M | Buy |
20,736
+2,490
| +14% | +$149K | 0.1% | 156 |
|
|
2020
Q1 | $1.02M | Sell |
18,246
-2,097
| -10% | -$128K | 0.09% | 153 |
|
|
2019
Q4 | $1.3M | Buy |
20,343
+290
| +1% | +$16.6K | 0.1% | 156 |
|
|
2019
Q3 | $1.02M | Buy |
20,053
+5,162
| +35% | +$243K | 0.08% | 164 |
|
|
2019
Q2 | $674K | Buy |
14,891
+3,978
| +36% | +$185K | 0.05% | 195 |
|
|
2019
Q1 | $520K | Sell |
10,913
-3,136
| -22% | -$156K | 0.04% | 220 |
|
|
2018
Q4 | $729K | Sell |
14,049
-4,300
| -23% | -$231K | 0.07% | 188 |
|
|
2018
Q3 | $1.14M | Sell |
18,349
-713
| -4% | -$42.3K | 0.09% | 179 |
|
|
2018
Q2 | $1.05M | Buy |
19,062
+6,831
| +56% | +$369K | 0.09% | 175 |
|
|
2018
Q1 | $768K | Buy |
12,231
+61
| +0.5% | +$3.92K | 0.07% | 171 |
|
|
2017
Q4 | $746K | Sell |
12,170
-587
| -5% | -$36.7K | 0.07% | 179 |
|
|
2017
Q3 | $814K | Hold |
12,757
| – | – | 0.08% | 168 |
|
|
2017
Q2 | $713K | Sell |
12,757
-2,836
| -18% | -$154K | 0.08% | 174 |
|
|
2017
Q1 | $850K | Sell |
15,593
-5,267
| -25% | -$289K | 0.1% | 167 |
|
|
2016
Q4 | $1.11M | Hold |
20,860
| – | – | 0.14% | 147 |
|
|
2016
Q3 | $1.11M | Buy |
20,860
+3,724
| +22% | +$239K | 0.14% | 150 |
|
|
2016
Q2 | $1.26M | Sell |
17,136
-8,254
| -33% | -$583K | 0.17% | 134 |
|
|
2016
Q1 | $1.65M | Buy |
25,390
+3,404
| +15% | +$215K | 0.18% | 119 |
|
|
2015
Q4 | $1.51M | Sell |
21,986
-1,072
| -5% | -$70.8K | 0.27% | 102 |
|
|
2015
Q3 | $1.36M | Sell |
23,058
-1,906
| -8% | -$121K | 0.21% | 122 |
|
|
2015
Q2 | $1.66M | Sell |
24,964
-14,900
| -37% | -$982K | 0.24% | 119 |
|
|
2015
Q1 | $2.57M | Sell |
39,864
-7
| -0% | -$438 | 0.37% | 96 |
|
|
2014
Q4 | $2.35M | Sell |
39,871
-2,254
| -5% | -$127K | 0.36% | 95 |
|
|
2014
Q3 | $2.16M | Sell |
42,125
-1,137
| -3% | -$56.8K | 0.34% | 101 |
|
|
2014
Q2 | $2.1M | Buy |
43,262
+990
| +2% | +$48.8K | 0.3% | 105 |
|
|
2014
Q1 | $2.19M | Sell |
42,272
-1,163
| -3% | -$61.9K | 0.31% | 92 |
|
|
2013
Q4 | $2.3M | Sell |
43,435
-755
| -2% | -$38.5K | 0.34% | 80 |
|
|
2013
Q3 | $2.04M | Buy |
44,190
+40,620
| +1,138% | +$1.78M | 0.33% | 85 |
|
|
2013
Q2 | $160K | Buy |
+3,570
| New | +$155K | 0.08% | 85 |
|
Other funds holding BMY
First Horizon Advisors's BMY Position: Q2 2025 in Review
First Horizon Advisors increased its Bristol-Myers Squibb (BMY) stake by 6% in Q2 2025, buying an estimated $1.31M and bringing the position to 472,974 shares worth $21.9M. The position accounts for 0.57% of the portfolio, ranked #57.
First Horizon Advisors first reported a position in BMY in Q2 2013 and has held it in 49 quarters since. The position peaked at $27.2M in Q1 2025. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- First Horizon Advisors held 472,974 shares of Bristol-Myers Squibb worth $21.9M as of Q2 2025.
- First Horizon Advisors bought 26,599 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.31M.
- Bristol-Myers Squibb made up 0.57% of First Horizon Advisors's portfolio in Q2 2025, its #57 holding.
- First Horizon Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Bristol-Myers Squibb position peaked at $27.2M in Q1 2025.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.